Bavarian Nordic said to have won $63M mpox vaccine contract from U.S.

Diy13 Bavarian Nordic ( OTCPK:BVNRY ) ( OTCPK:BVNKF ) has secured a U.S. government contract worth $63M to manufacture components for Jynneos, its FDA-approved vaccine for mpox and smallpox, Reuters reported Tuesday, citing the company.

Per the terms, the Danish biotech is expected to manufacture 1M.